Emerging Roles of Chemokines in Cancer Immunotherapy
Funding
Conflicts of Interest
References
- Del Molino del Barrio, I.; Meeson, A.; Cooke, K.; Malki, M.I.; Barron-Millar, B.; Kirby, J.A.; Ali, S. Contribution of Heparan Sulphate Binding in CCL21-Mediated Migration of Breast Cancer Cells. Cancers 2021, 13, 3462. [Google Scholar] [CrossRef] [PubMed]
- De Zutter, A.; Crijns, H.; Berghmans, N.; García-Caballero, M.; Vanbrabant, L.; Pörtner, N.; Vanheule, V.; Verscheure, P.; Siddiquei, M.M.; Abu El-Asrar, A.M.; et al. The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors. Cancers 2021, 13, 5090. [Google Scholar] [CrossRef] [PubMed]
- Erlichman, N.; Baram, T.; Meshel, T.; Morein, D.; Da’adoosh, B.; Ben-Baruch, A. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042. [Google Scholar] [CrossRef] [PubMed]
- Erlichman, N.; Baram, T.; Meshel, T.; Morein, D.; Da’adoosh, B.; Ben-Baruch, A. Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042, Cancers2022, 14, 2579. [Google Scholar] [CrossRef] [PubMed]
- Matsuo, K.; Yoshie, O.; Nakayama, T. Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity. Cancers 2021, 13, 6132. [Google Scholar] [CrossRef] [PubMed]
- Karin, N. Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones? Cancers 2021, 13, 6317. [Google Scholar] [CrossRef] [PubMed]
- Adams, R.; Moser, B.; Karagiannis, S.N.; Lacy, K.E. Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician. Cancers 2021, 13, 5625. [Google Scholar] [CrossRef] [PubMed]
- Isci, D.; D’Uonnolo, G.; Wantz, M.; Rogister, B.; Lombard, A.; Chevigné, A.; Szpakowska, M.; Neirinckx, V. Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma. Cancers 2022, 14, 130. [Google Scholar] [CrossRef] [PubMed]
- Yoshie, O. CCR4 as a Therapeutic Target for Cancer Immunotherapy. Cancers 2021, 13, 5542. [Google Scholar] [CrossRef] [PubMed]
- Mezzapelle, R.; Leo, M.; Caprioglio, F.; Colley, L.S.; Lamarca, A.; Sabatino, L.; Colantuoni, V.; Crippa, M.P.; Bianchi, M.E. CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy. Cancers 2022, 14, 2314. [Google Scholar] [CrossRef] [PubMed]
- Moser, B. Chemokine Receptor-Targeted Therapies: Special Case for CCR8. Cancers 2022, 14, 511. [Google Scholar] [CrossRef] [PubMed]
- Bullock, K.; Richmond, A. Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy. Cancers 2021, 13, 6293. [Google Scholar] [CrossRef] [PubMed]
- Bonecchi, R.; Mantovani, A.; Jaillon, S. Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy. Cancers 2022, 14, 680. [Google Scholar] [CrossRef] [PubMed]
- Hsieh, C.-H.; Jian, C.-Z.; Lin, L.-I.; Low, G.-S.; Ou, P.-Y.; Hsu, C.; Ou, D.-L. Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer. Cancers 2022, 14, 294. [Google Scholar] [CrossRef] [PubMed]
- Schlecht-Louf, G.; Deback, C.; Bachelerie, F. The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy. Cancers 2022, 14, 848. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Moser, B. Emerging Roles of Chemokines in Cancer Immunotherapy. Cancers 2022, 14, 3593. https://doi.org/10.3390/cancers14153593
Moser B. Emerging Roles of Chemokines in Cancer Immunotherapy. Cancers. 2022; 14(15):3593. https://doi.org/10.3390/cancers14153593
Chicago/Turabian StyleMoser, Bernhard. 2022. "Emerging Roles of Chemokines in Cancer Immunotherapy" Cancers 14, no. 15: 3593. https://doi.org/10.3390/cancers14153593